Phio Pharmaceuticals
PHIO
#10807
Rank
S$16.1 M
Marketcap
S$1.39
Share price
-3.54%
Change (1 day)
-49.07%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2026 (TTM): -S$14.03 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -S$11.06 Million a decrease over its 2024 earnings that were of -S$9.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$14.03 Million26.8%
2025 -S$11.06 Million21.65%
2024 -S$9.1 Million-33.96%
2023 -S$13.77 Million-5.7%
2022 -S$14.6 Million-13.6%
2021 -S$16.9 Million51.09%
2020 -S$11.19 Million-1.28%
2019 -S$11.33 Million21.03%
2018 -S$9.36 Million-53.1%
2017 -S$19.96 Million74.49%
2016 -S$11.44 Million-12.02%
2015 -S$13 Million16.17%
2014 -S$11.19 Million-57.95%
2013 -S$26.61 Million62.45%
2012 -S$16.38 Million0.87%
2011 -S$16.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.3 Billion 1,994.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.09 Million 66.08%๐Ÿ‡บ๐Ÿ‡ธ USA